Literature DB >> 3045242

Role of activated macrophages in resistance to systemic candidosis.

A Baghian1, K W Lee.   

Abstract

To evaluate further the contribution of activated macrophages in resistance, the course of systemic candidosis was assayed in beige and NLM mice that had been previously infected with Mycobacterium bovis (BCG). Four weeks following BCG infection, mice were inoculated intravenously with 1 x 10(4) viable Candida albicans. At various times thereafter, the number of C. albicans colony-forming units in the livers, spleens, and kidneys was determined. The average number of CFU recovered from the kidneys of NLM mice decreased throughout the assay and was comparable in both BCG-treated and control mice. In contrast, the number of CFU cultured from the kidneys of untreated control beige mice progressively increased throughout the assay period. This profile of renal susceptibility was not appreciably altered in BCG-treated beige mice. However, fewer (10- to 100-fold) CFU were cultured from the livers and spleens of BCG-treated beige and NLM mice than from untreated controls. These results support the hypothesis that in the absence of functional polymorphonuclear leukocytes, activated macrophages represent a means to control the proliferation of C. albicans.

Entities:  

Mesh:

Year:  1988        PMID: 3045242     DOI: 10.1002/jlb.44.3.166

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  11 in total

1.  Effects of glycyrrhizin, an active component of licorice roots, on Candida albicans infection in thermally injured mice.

Authors:  T Utsunomiya; M Kobayashi; D N Herndon; R B Pollard; F Suzuki
Journal:  Clin Exp Immunol       Date:  1999-05       Impact factor: 4.330

2.  Eucalyptus globulus (eucalyptus) treatment of candidiasis in normal and diabetic rats.

Authors:  Mohammad Bokaeian; Alireza Nakhaee; Bita Moodi; Hossein Ali Khazaei
Journal:  Iran Biomed J       Date:  2010-07

3.  Role of L3T4+ lymphocytes in protective immunity to systemic Candida albicans infection in mice.

Authors:  E Cenci; L Romani; A Vecchiarelli; P Puccetti; F Bistoni
Journal:  Infect Immun       Date:  1989-11       Impact factor: 3.441

4.  Mucosal and systemic candidiasis in congenitally immunodeficient mice.

Authors:  M T Cantorna; E Balish
Journal:  Infect Immun       Date:  1990-04       Impact factor: 3.441

5.  Non-serum-dependent chemotactic factors produced by Candida albicans stimulate chemotaxis by binding to the formyl peptide receptor on neutrophils and to an unknown receptor on macrophages.

Authors:  H A Edens; C A Parkos; T W Liang; A J Jesaitis; J E Cutler; H M Miettinen
Journal:  Infect Immun       Date:  1999-03       Impact factor: 3.441

6.  Integrin αXβ₂ is a leukocyte receptor for Candida albicans and is essential for protection against fungal infections.

Authors:  Samir Jawhara; Elzbieta Pluskota; Dmitriy Verbovetskiy; Olena Skomorovska-Prokvolit; Edward F Plow; Dmitry A Soloviev
Journal:  J Immunol       Date:  2012-07-27       Impact factor: 5.422

7.  Mechanism for candidacidal activity in macrophages activated by recombinant gamma interferon.

Authors:  K Watanabe; K Kagaya; T Yamada; Y Fukazawa
Journal:  Infect Immun       Date:  1991-02       Impact factor: 3.441

8.  Effects of garlic extract treatment in normal and streptozotocin diabetic rats infected with Candida albicans.

Authors:  M Bokaeian; A Nakhaee; Bita Moodi; A Farhangi; Azim Akbarzadeh
Journal:  Indian J Clin Biochem       Date:  2010-05-27

9.  In vitro study of contact-mediated killing of Candida albicans hyphae by activated murine peritoneal macrophages in a serum-free medium.

Authors:  T Hashimoto
Journal:  Infect Immun       Date:  1991-10       Impact factor: 3.441

10.  Macrophage colony-stimulating factor in murine candidiasis: serum and tissue levels during infection and protective effect of exogenous administration.

Authors:  E Cenci; A Bartocci; P Puccetti; S Mocci; E R Stanley; F Bistoni
Journal:  Infect Immun       Date:  1991-03       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.